Proteomic and Morphologic Evidences for Taurine-5-Bromosalicylaldehyde Schiff Base as an Efficient Anti-Mycobacterial Drug.

Mycobacterium tuberculosis, a causative pathogen of tuberculosis (TB), still threats human health worldwide. To find a novel drug to eradicate this pathogen, we tried taurine-5- bromosalicylaldehyde Schiff base (TBSSB) as an innovative anti-mycobacterial drug using Mycobacterium. smegmatis as a surrogate model for M. tuberculosis. We investigated the antimicrobial activity of TBSSB against M. smegmatis by plotting growth curves, examined the effect of TBSSB on biofilm formation, observed morphological changes by scanning electron microscopy and transmission electron microscopy, and detected differentially expressed proteins using two dimensional gel electrophoresis coupled with mass spectrometry. TBSSB inhibited mycobacterial growth and biofilm formation, altered cell ultrastructure and intracellular content, and inhibited cell division. Furthermore, M. smegmatis adapted itself to TBSSB inhibition by regulating the metabolic pathways and enzymatic activities of the identified proteins. NDMA-dependent methanol dehydrogenase, NAD(P)H nitroreductase, and amidohydrolase AmiB1 appear to be pivotal factors to regulate the M. smegmatis survival under TBSSB. Our dataset reinforced the idea that Schiff base-taurine compounds have the potential to be developed as novel anti-mycobacterial drugs.

[1]  Yuefei Xu,et al.  Deficiency of D‐alanyl‐D‐alanine ligase A attenuated cell division and greatly altered the proteome of Mycobacterium smegmatis , 2019, MicrobiologyOpen.

[2]  Hyun‐Seok Kim,et al.  In vitro cytotoxicity activity of novel Schiff base ligand–lanthanide complexes , 2018, Scientific Reports.

[3]  Yuefei Xu,et al.  The Biological Properties and Potential Interacting Proteins of d-Alanyl-d-alanine Ligase A from Mycobacterium tuberculosis , 2018, Molecules.

[4]  B. Gicquel,et al.  Phenotypic and genomic comparison of Mycobacterium aurum and surrogate model species to Mycobacterium tuberculosis: implications for drug discovery , 2017, BMC Genomics.

[5]  R. Koder,et al.  Mechanism-Informed Refinement Reveals Altered Substrate-Binding Mode for Catalytically Competent Nitroreductase. , 2017, Structure.

[6]  P. Mishra,et al.  Metal Complexes of a Novel Schiff Base Based on Penicillin: Characterization, Molecular Modeling, and Antibacterial Activity Study , 2017, Bioinorganic chemistry and applications.

[7]  Min Yang,et al.  Novel TetR family transcriptional factor regulates expression of multiple transport-related genes and affects rifampicin resistance in Mycobacterium smegmatis , 2016, Scientific Reports.

[8]  G. Besra,et al.  Assembly of the Mycobacterial Cell Wall. , 2015, Annual review of microbiology.

[9]  J. Sacchettini,et al.  Peptidoglycan synthesis in Mycobacterium tuberculosis is organized into networks with varying drug susceptibility , 2015, Proceedings of the National Academy of Sciences.

[10]  S. Miryala,et al.  Use of Mycobacterium smegmatis Deficient in ADP-Ribosyltransferase as Surrogate for Mycobacterium tuberculosis in Drug Testing and Mutation Analysis , 2015, PloS one.

[11]  Helen L Birch,et al.  The Mycobacterial Cell Wall--Peptidoglycan and Arabinogalactan. , 2015, Cold Spring Harbor perspectives in medicine.

[12]  Shanshan Huang,et al.  In vitro activity of taurine-5-bromosalicylaldehyde Schiff base against planktonic and biofilm cultures of methicillin-resistant Staphylococcus aureus. , 2014, Journal of microbiology and biotechnology.

[13]  Tao Xu,et al.  DNA binding, DNA cleavage and BSA interaction of a mixed-ligand copper(II) complex with taurine Schiff base and 1,10-phenanthroline. , 2013, Journal of photochemistry and photobiology. B, Biology.

[14]  Hannah R. Meredith,et al.  Programmed cell death in bacteria and implications for antibiotic therapy. , 2013, Trends in microbiology.

[15]  K. Thalassinos,et al.  Crystal Structure of Reduced MsAcg, a Putative Nitroreductase from Mycobacterium smegmatis and a Close Homologue of Mycobacterium tuberculosis Acg , 2012, The Journal of Biological Chemistry.

[16]  A. Joachimiak,et al.  A conformational switch controls cell wall‐remodelling enzymes required for bacterial cell division , 2012, Molecular microbiology.

[17]  L. Kremer,et al.  Exposure of Mycobacteria to Cell Wall-inhibitory Drugs Decreases Production of Arabinoglycerolipid Related to Mycolyl-arabinogalactan-peptidoglycan Metabolism* , 2012, The Journal of Biological Chemistry.

[18]  T. Bernhardt,et al.  A Fail-Safe Mechanism in the Septal Ring Assembly Pathway Generated by the Sequential Recruitment of Cell Separation Amidases and Their Activators , 2011, Journal of bacteriology.

[19]  Philippe Chaignon,et al.  NADH oxidase activity of Bacillus subtilis nitroreductase NfrA1: Insight into its biological role , 2010, FEBS letters.

[20]  A. Fluitt,et al.  A Kinetic Study of In Vitro Lysis of Mycobacterium smegmatis. , 2009, Chemical engineering science.

[21]  Andreas Burkovski,et al.  A Genomic View of Sugar Transport in Mycobacterium smegmatis and Mycobacterium tuberculosis , 2007, Journal of bacteriology.

[22]  T. Beddoe,et al.  Expression, purification, crystallization and preliminary X-ray diffraction analysis of an essential lipoprotein implicated in cell-wall biosynthesis in Mycobacteria. , 2005, Acta crystallographica. Section F, Structural biology and crystallization communications.

[23]  L. Dijkhuizen,et al.  Identification of a Magnesium-dependent NAD(P)(H)-binding Domain in the Nicotinoprotein Methanol Dehydrogenase from Bacillus methanolicus * , 2002, The Journal of Biological Chemistry.

[24]  Mary Jackson,et al.  Cell Wall Core Galactofuran Synthesis Is Essential for Growth of Mycobacteria , 2001, Journal of bacteriology.

[25]  K. Lewis,et al.  Programmed Death in Bacteria , 2000, Microbiology and Molecular Biology Reviews.

[26]  J. Tyagi,et al.  Mycobacterium tuberculosis rrnPromoters: Differential Usage and Growth Rate-Dependent Control , 1999, Journal of bacteriology.

[27]  Simon Paul,et al.  Mycobacterium tuberculosis Catalase and Peroxidase Activities and Resistance to Oxidative Killing in Human Monocytes In Vitro , 1999, Infection and Immunity.

[28]  A. Pui,et al.  Antibacterial activity of Pd(II) complexes with salicylaldehyde-amino acids Schiff bases ligands. , 2014, Chemical & pharmaceutical bulletin.

[29]  L. Gabbasova,et al.  Global tuberculosis report (2014) , 2014 .

[30]  Di Chen,et al.  Induction of tumor cell apoptosis by taurine Schiff base copper complex is associated with the inhibition of proteasomal activity. , 2008, International journal of molecular medicine.

[31]  D. Crick,et al.  Expression, essentiality, and a microtiter plate assay for mycobacterial GlmU, the bifunctional glucosamine-1-phosphate acetyltransferase and N-acetylglucosamine-1-phosphate uridyltransferase. , 2008, The international journal of biochemistry & cell biology.